SCHEMBL8729080

SCHEMBL8729080

CC(C)(C)c1ccc(C(=O)O)c(C(N)=O)c1-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CSNK1E P49674 5/20 0.39
FABP4 P15090 2/20 0.38
BCAT2 O15382 1/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
GAA P10253 1/20 0.37
ALDH1A1 P00352 2/20 0.36
CSNK1D P48730 1/20 0.36
HNF4A P41235 2/20 0.36
ACMSD Q8TDX5 1/20 0.36
KDM4E B2RXH2 1/20 0.35
DHODH Q02127 1/20 0.35
HPGD P15428 1/20 0.35
MAPT P10636 1/20 0.35
MYC P01106 1/20 0.35
BRD4 O60885 1/20 0.35
MAP2 P11137 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28992365 0.83 BCAT2 (0.44) CSNK1EBCAT2KMT2AMEN1ALDH1A1
SCHEMBL28065801 0.80 HNF4A (0.50) FABP4ALDH1A1HNF4AACMSDKDM4E
SCHEMBL15741932 0.75 TSHR (0.45) FABP4KMT2AMEN1GAAALDH1A1
SCHEMBL8729082 0.74 MYC (0.46) BCAT2KMT2AALDH1A1HNF4AMAPT
SCHEMBL30728189 0.74 CYP1A2 (0.46) FABP4BCAT2KMT2AMEN1GAA
SCHEMBL8674376 0.71 GABRP (0.42) ALDH1A1KDM4EDHODH
SCHEMBL10950361 0.71 ALDH1A1 (0.41) FABP4KMT2AALDH1A1HNF4AACMSD
SCHEMBL31028133 0.70 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDMAPT
SCHEMBL39249 0.70 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDMAPT
SCHEMBL2875497 0.70 FABP4 (0.51) FABP4KMT2AALDH1A1HNF4AACMSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869782-A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY Vision Pharmaceuticals L.P. (US) 1998-10-14 EP disclosed
WO-1997024116-A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY VISION PHARMACEUTICALS L.P. (US) 1997-07-10 WO disclosed